Authors
Gang Luo, Qianqian Zhang, Chenhao Wang, Zhiheng Yi, Alex Jinpeng Wang, Jing Tang, Min Li
Published in
Advanced science (Weinheim, Baden-Wurttemberg, Germany). Pages e77238. Sep 10, 2026. Epub Sep 10, 2026.
Abstract
Unifying drug-target affinity prediction and targeted molecular design within a single interpretable framework remains challenging. Many sequence-based affinity and design methods rely on global target representations without explicitly modeling binding regions, leading to site-level ambiguity in both screening and design. By contrast, structure-based methods require high-quality structural data and are poorly suited to dynamic targets. In this study, a new model named MolDBG is proposed as a unified site-aware framework that combines affinity prediction, binding-site identification, and affinity-conditioned molecular generation within a single architecture. With binding-site supervision, MolDBG prioritizes interaction-critical residues before learning drug-target representations, reducing false positives from misaligned binding sites and improving interpretability. MolDBG achieves competitive performance across all three tasks while enabling site-specific affinity prediction and interpretable binding-site discovery. The framework generalizes to structurally elusive targets, including cryptic pockets and intrinsically disordered proteins. Overall, these results demonstrate that MolDBG is a promising framework for molecular design and screening.
PMID:
42723155
Bibliographic data and abstract were imported from PubMed on 11 Sep 2026.
Read full publication at:
Please sign in
to see all details.
Advertisement
Stats
- Recommendations n/a n/a positive of 0 vote(s)
- Views 8
- Comments 0